Laser therapy of esophageal or rectal cancer gives opportunity to withdraw temporarily symptoms of dysphagia or obstruction due to immediate vaporization of exophytic part of neoplastic tumor and exfoliation of coagulated deeper tissue. This therapy improves life comfort of patients suffering from esophageal and rectal cancer in cases when radical therapy is impossible. 58 laser vaporization of esophageal cancer in inoperable patients with ASA IV and V were performed from January 2008 to October 2011. 42 suffered from squamous-cell cancer, 16 – from esophageal adenocarcinoma localized endoscopically from 20 to 40 cm, administering 2 – 9 kJ of heat. Also 18 laser vaporisations of rectal cancer were performed, administering 4 - 18 kJ of heat. 1,6 sessions (1-5 sessions) with high-energy laser were performed on average, adjusting laser power for 70 W and performing photo-destruction of the esophageal neoplastic tumor with mortality of 2%. The average for rectal cancer were 1,1 sessions (1-2) with time asymptomatic of subileus from 8 to 33 months, mortality 5,5%. Laser vaporisation of gastrointestinal tract lesions is: 1. Alternative action in relation to other procedures regarding restoration of patency of the esophagus and the rectum in inoperable patients; 2. It is distinguished by short hospitalization time and low complications rate.
| Published in | Journal of Surgery (Volume 3, Issue 1) |
| DOI | 10.11648/j.js.20150301.12 |
| Page(s) | 4-7 |
| Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
| Copyright |
Copyright © The Author(s), 2024. Published by Science Publishing Group |
Esophageal Cancer, Rectal Cancer, Laser Vaporisation
| [1] | Wojciechowska U., Didkowska J., Zatoński W.: Nowotwory złośliwe w Polsce w 2008 roku; Krajowy Rejestr Nowotworów, Centrum Onkologii, Warszawa 2010. |
| [2] | Jih M., Kimyai-Asadi A.: Fractional photothermolysis: a review and update. Semin Cutan Med Surg. 2008 Mar;27(1):63-71. |
| [3] | Rao V., et al: Endoscopic laser ablation of advanced rectal carcinoma; Colorectal Dis. 2005; 7(1): 58-60 |
| [4] | Courtney E., et al.: Eight years experience of high-powered endoscopic diode laser therapy for palliation of colorectal carcinoma. Colon Rectum. 2005 Apr;48(4):845-50. |
| [5] | Javle M. et al: Palliation of malignant dysphagia in esophageal cancer: a literature-based review. J Support Oncol. 2006 Sep;4(8):365-73, 379. |
| [6] | Courtney ED, Raja A, Leicester RJ.: Eight years experience of high-powered endoscopic diode laser therapy for palliation of colorectal carcinoma. Dis Colon Rectum. 2005 Apr;48(4):845-50. |
| [7] | Thompson AM. et al: Endoscopic palliative treatment for esophageal and gastric cancer: techniques, complications, and survival in a population-based cohort of 948 patients. Surg Endosc. 2004 Aug;18(8):1257-62. Epub 2004 May 28. PubMed PMID: 15164283. |
| [8] | Kozarek RA.: Endoscopic palliation of esophageal malignancy. Endoscopy. 2003 Aug;35(8):S9-13. |
| [9] | Lambert R.: Treatment of esophagogastric tumors. Endoscopy. 2003 Feb;35(2):118-26. |
| [10] | Aly EA, Burgess P.: Use of laser in the relief of malignant dysphagia: a district hospital experience. Dig Surg. 2002;19(1):3-8. |
| [11] | Imran H.: Management of stage IV rectal cancer: Palliative opions; World J Gastroenterol 2011 February 21; 17(7): 835-847 |
APA Style
Leszek Stefanski, Pawel Lampe. (2015). Laser Vaporization of Inoperable Esophageal and Rectal Cancer. Why We Use this Therapy. Journal of Surgery, 3(1), 4-7. https://doi.org/10.11648/j.js.20150301.12
ACS Style
Leszek Stefanski; Pawel Lampe. Laser Vaporization of Inoperable Esophageal and Rectal Cancer. Why We Use this Therapy. J. Surg. 2015, 3(1), 4-7. doi: 10.11648/j.js.20150301.12
AMA Style
Leszek Stefanski, Pawel Lampe. Laser Vaporization of Inoperable Esophageal and Rectal Cancer. Why We Use this Therapy. J Surg. 2015;3(1):4-7. doi: 10.11648/j.js.20150301.12
Share This Article
Twitter
Linked In
Facebook
Copy
Download@article{10.11648/j.js.20150301.12,
author = {Leszek Stefanski and Pawel Lampe},
title = {Laser Vaporization of Inoperable Esophageal and Rectal Cancer. Why We Use this Therapy},
journal = {Journal of Surgery},
volume = {3},
number = {1},
pages = {4-7},
doi = {10.11648/j.js.20150301.12},
url = {https://doi.org/10.11648/j.js.20150301.12},
eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.js.20150301.12},
abstract = {Laser therapy of esophageal or rectal cancer gives opportunity to withdraw temporarily symptoms of dysphagia or obstruction due to immediate vaporization of exophytic part of neoplastic tumor and exfoliation of coagulated deeper tissue. This therapy improves life comfort of patients suffering from esophageal and rectal cancer in cases when radical therapy is impossible. 58 laser vaporization of esophageal cancer in inoperable patients with ASA IV and V were performed from January 2008 to October 2011. 42 suffered from squamous-cell cancer, 16 – from esophageal adenocarcinoma localized endoscopically from 20 to 40 cm, administering 2 – 9 kJ of heat. Also 18 laser vaporisations of rectal cancer were performed, administering 4 - 18 kJ of heat. 1,6 sessions (1-5 sessions) with high-energy laser were performed on average, adjusting laser power for 70 W and performing photo-destruction of the esophageal neoplastic tumor with mortality of 2%. The average for rectal cancer were 1,1 sessions (1-2) with time asymptomatic of subileus from 8 to 33 months, mortality 5,5%. Laser vaporisation of gastrointestinal tract lesions is: 1. Alternative action in relation to other procedures regarding restoration of patency of the esophagus and the rectum in inoperable patients; 2. It is distinguished by short hospitalization time and low complications rate.},
year = {2015}
}
TY - JOUR T1 - Laser Vaporization of Inoperable Esophageal and Rectal Cancer. Why We Use this Therapy AU - Leszek Stefanski AU - Pawel Lampe Y1 - 2015/01/23 PY - 2015 N1 - https://doi.org/10.11648/j.js.20150301.12 DO - 10.11648/j.js.20150301.12 T2 - Journal of Surgery JF - Journal of Surgery JO - Journal of Surgery SP - 4 EP - 7 PB - Science Publishing Group SN - 2330-0930 UR - https://doi.org/10.11648/j.js.20150301.12 AB - Laser therapy of esophageal or rectal cancer gives opportunity to withdraw temporarily symptoms of dysphagia or obstruction due to immediate vaporization of exophytic part of neoplastic tumor and exfoliation of coagulated deeper tissue. This therapy improves life comfort of patients suffering from esophageal and rectal cancer in cases when radical therapy is impossible. 58 laser vaporization of esophageal cancer in inoperable patients with ASA IV and V were performed from January 2008 to October 2011. 42 suffered from squamous-cell cancer, 16 – from esophageal adenocarcinoma localized endoscopically from 20 to 40 cm, administering 2 – 9 kJ of heat. Also 18 laser vaporisations of rectal cancer were performed, administering 4 - 18 kJ of heat. 1,6 sessions (1-5 sessions) with high-energy laser were performed on average, adjusting laser power for 70 W and performing photo-destruction of the esophageal neoplastic tumor with mortality of 2%. The average for rectal cancer were 1,1 sessions (1-2) with time asymptomatic of subileus from 8 to 33 months, mortality 5,5%. Laser vaporisation of gastrointestinal tract lesions is: 1. Alternative action in relation to other procedures regarding restoration of patency of the esophagus and the rectum in inoperable patients; 2. It is distinguished by short hospitalization time and low complications rate. VL - 3 IS - 1 ER -
Information
Email: